Columnist Anna Jeter shares her journey of embracing visibility and redefining her own definition of disabled after a ...

Apelin delivered by extracellular vesicles to damaged lungs was found to ease PAH in animal models of the disease, per a ...

Columnist Jen Cueva talks with fellow patient Jolie Lizana about her journey to becoming a patient advocate and columnist for ...

A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

James Ramsey shares how he continues to sing, dance, and perform after his pulmonary arterial hypertension diagnosis.

The therapy was preferred by nearly all trial participants who switched to it from Tyvaso, an older inhaled treprostinil formulation marketed by United Therapeutics. Full trial results were detailed ...